COMMUNIQUÉS West-GlobeNewswire

Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2023 et de son Rapport Annuel 2023 (« Form 20-F »)

03/04/2024 - 22:00

Daix (France), Long Island City (New York, United States), le 3 avril 2024 – Inventiva (Euronext Paris et Nasdaq : IVA) (la "Société"), société biopharmaceutique spécialisée dans le développement clinique de petites [...]

Two Legend Senior Living® Directors Receive Prestigious Hero Awards From the Texas Assisted Living Association (TALA)

03/04/2024 - 22:00

DALLAS, April 03, 2024 (GLOBE NEWSWIRE) -- Legend Senior Living announced today that Chris Tucker, Health Care Director, Legend of Fort Worth (TX), and Haley Moore, Sales Director, Rock Ridge in Rockwall (TX), are both [...]

Merus participera à une discussion informelle lors de la 23e conférence annuelle Needham Virtual Healthcare

03/04/2024 - 20:23

UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 03 avr. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), une société spécialisée dans l’oncologie au stade clinique développant des anticorps de pleine longueur [...]

UPDATE – Redhook Brewery Announces New “Big Juicy Ballard” IPA and Revives IPA Daze Festival at the Brewlab on 4/20 Weekend

03/04/2024 - 20:02

Redhook Unveils the Latest Addition to Their Thriving Big Ballard family of IPAs, Hitting Shelves this Month SEATTLE, April 03, 2024 (GLOBE NEWSWIRE) -- Redhook Brewery , makers of pure Pacific Northwest ale, and a [...]

NH Nonprofit Heralds New Research Documenting Community Healthcare Workers

03/04/2024 - 20:00

Impacts: More Cancer Screenings, Lower Healthcare Costs Littleton, NH, April 03, 2024 (GLOBE NEWSWIRE) -- North Country Health Consortium, the New Hampshire nonprofit tasked by state officials to increase awareness and [...]

IBEX Shareholders Approve Sale of the Company

03/04/2024 - 18:36

MONTRÉAL, Québec, April 03, 2024 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) is pleased to announce that at an annual and special meeting held today, IBEX shareholders [...]

CARBIOS annonce le vif succès de son premier plan d'actionnariat salarié

03/04/2024 - 18:30

CARBIOS annonce le vif succès de son premier plan d'actionnariat salarié Taux de participation record avec 88,49% des collaborateurs éligibles qui ont souscrits à l’opération Un plan comprenant un abondement unilatéral [...]

AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS

03/04/2024 - 18:09

PRESS RELEASE AB SCIENCE ANNOUNCES THAT HEALTH CANADA HAS GRANTED ELIGIBILITY FOR RECONSIDERATION REQUEST FOR MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS Paris, 3 April, 2024, 6pm CET AB Science SA (Euronext - [...]

AB Science annonce que Santé Canada a jugé admissible la demande de réexamen du masitinib dans SLA

03/04/2024 - 18:09

COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE QUE SANTÉ CANADA A JUGÉ ADMISSIBLE LA DEMANDE DE RÉEXAMEN DU MASITINIB DANS LA SCLÉROSE LATÉRALE AMYOTROPHIQUE Paris, 3 avril 2024, 18h AB Science SA (Euronext - FR0010557264 - AB [...]

Transparency Notifications from Shareholders

03/04/2024 - 18:00

PRESS RELEASE REGULATED INFORMATION 3 April 2024, 06:00 pm CEST Ghent, Belgium – 3 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of fluid [...]

Informations relatives au nombre total de droits de vote et d’actions composant le capital

03/04/2024 - 18:00

Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 3 avril 2024 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement [...]

Le KFSH&RC accueille le Dr Björn Zoëga en tant que nouveau directeur général adjoint

03/04/2024 - 17:37

RIYAD, Arabie saoudite, 03 avr. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH&RC) est fier d’annoncer la nomination du Dr Björn Zoëga au poste de directeur général adjoint, à [...]

ALPHA PRO TECH, LTD. ANNOUNCES $2 MILLION EXPANSION OF SHARE REPURCHASE PROGRAM

03/04/2024 - 17:30

Nogales, Arizona, April 03, 2024 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American: APT) , a leading manufacturer of products designed to protect people, products and environments, including disposable protective [...]

Clearday to Present at the Emerging Growth Conference on April 4, 2024

03/04/2024 - 16:20

Clearday invites individual and institutional investors, advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference. San Antonio, TX, April 03, 2024 (GLOBE NEWSWIRE) -- [...]

Major shareholder announcement – Swedbank Robur Fonder AB

03/04/2024 - 16:05

ANNOUNCEMENT NO. 259 Major shareholder announcement Major shareholder announcement – Swedbank Robur Fonder AB Pursuant to Section 38 of the Danish Capital Markets Act, it is hereby announced that Swedbank Robur Fonder [...]

Grant of share-based long-term incentive instruments to members of the Board of Management and key employees

03/04/2024 - 15:40

ALK ( ALKB:DC / OMX: ALK B / AKBLF ): According to the Company’s remuneration policy adopted at the Company's Annual General Meeting on 23 March 2023 and in line with the Company’s usual practice, the Board of Directors [...]

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN NAPLES FLORIDA

03/04/2024 - 15:25

MINNEAPOLIS, April 03, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for [...]

TransCode Therapeutics Reports 2023 Results; Provides Business Update

03/04/2024 - 15:10

BOSTON, April 03, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today reported financial results for [...]

ARS Pharmaceuticals Submits Response to FDA Complete Response Letter for neffy® (Epinephrine Nasal Spray)

03/04/2024 - 15:01

Response addresses all additional requests in FDA CRL, including positive data from a repeat dose PK/PD study of neffy under nasal allergen challenge (NAC) conditions, and updated testing that detected no measurable [...]